| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |